Galantamine
Published in Handbook of Metabolic Pathways of Xenobiotics • Oct 13, 2013
NobleIDNI1P89W11R48S08
Authors:
Jinghua Yu
Abstract
Galantamine is a competitive and reversible cholinesterase inhibitor used for the treatment of mild to moderate Alzheimer's disease and various other memory impairments. The metabolism and excretion of [ 3 H]‐galantamine in healthy male adult subjects were investigated. After an oral dose of 4 mg, t...
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!